Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CAH Cardinal Health	$205.79 +2.0%	$202.53	$137.75 ▼ $233.60	$48.18B	0.52	2.21 million shs	1.59 million shs
COR Cencora	$274.94 +1.7%	$292.70	$244.82 ▼ $377.54	$52.59B	0.59	1.94 million shs	1.29 million shs
HUM Humana	$349.85 +0.0%	$248.43	$163.11 ▼ $351.88	$42.00B	0.76	1.59 million shs	1.74 million shs
MCK McKesson	$776.51 +2.6%	$806.32	$637.00 ▼ $999.00	$90.99B	0.31	1.30 million shs	981,963 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CAH Cardinal Health	+2.03%	+4.69%	+7.51%	-5.55%	+33.46%
COR Cencora	+1.78%	+2.13%	+8.59%	-23.20%	-4.87%
HUM Humana	0.00%	+14.34%	+41.88%	+95.15%	+51.64%
MCK McKesson	+2.62%	+4.73%	+4.63%	-15.45%	+9.38%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CAH Cardinal Health	$205.79 +2.0%	$202.53	$137.75 ▼ $233.60	$48.18B	0.52	2.21 million shs	1.59 million shs
COR Cencora	$274.94 +1.7%	$292.70	$244.82 ▼ $377.54	$52.59B	0.59	1.94 million shs	1.29 million shs
HUM Humana	$349.85 +0.0%	$248.43	$163.11 ▼ $351.88	$42.00B	0.76	1.59 million shs	1.74 million shs
MCK McKesson	$776.51 +2.6%	$806.32	$637.00 ▼ $999.00	$90.99B	0.31	1.30 million shs	981,963 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CAH Cardinal Health	+2.03%	+4.69%	+7.51%	-5.55%	+33.46%
COR Cencora	+1.78%	+2.13%	+8.59%	-23.20%	-4.87%
HUM Humana	0.00%	+14.34%	+41.88%	+95.15%	+51.64%
MCK McKesson	+2.62%	+4.73%	+4.63%	-15.45%	+9.38%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CAH Cardinal Health	2.94	Moderate Buy	$241.80	17.50% Upside
COR Cencora	2.80	Moderate Buy	$380.25	38.30% Upside
HUM Humana	2.25	Hold	$279.30	-20.17% Downside
MCK McKesson	2.82	Moderate Buy	$968.87	24.77% Upside

Current Analyst Ratings Breakdown

Latest COR, MCK, CAH, and HUM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/4/2026	HUM Humana	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Underweight	$217.00 ➝ $249.00
6/4/2026	HUM Humana	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
6/4/2026	HUM Humana	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$267.00 ➝ $340.00
6/3/2026	HUM Humana	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$425.00
6/1/2026	HUM Humana	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sector Perform
6/1/2026	HUM Humana	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$270.00 ➝ $320.00
5/26/2026	HUM Humana	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$180.00 ➝ $344.00
5/22/2026	COR Cencora	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B) ➝ Buy (B-)
5/22/2026	HUM Humana	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$262.00 ➝ $320.00
5/20/2026	HUM Humana	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral ➝ Overweight
5/20/2026	HUM Humana	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform

(Data available from 6/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CAH Cardinal Health	$250.74B	0.19	$11.90 per share	17.29	($11.04) per share	-18.64
COR Cencora	$638.56M	83.77	$21.98 per share	12.51	$9.01 per share	30.51
HUM Humana	$129.66B	0.32	$24.06 per share	14.54	$147.47 per share	2.37
MCK McKesson	$403.43B	0.23	$46.75 per share	16.61	($14.51) per share	-53.52

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CAH Cardinal Health	$1.56B	$6.54	31.47	17.18	1.10	0.62%	-92.61%	4.46%	8/11/2026 (Estimated)
COR Cencora	$1.55B	$13.04	21.08	13.96	1.46	0.78%	135.20%	4.20%	8/5/2026 (Estimated)
HUM Humana	$1.19B	$9.35	37.42	23.85	2.00	0.82%	10.45%	3.75%	7/29/2026 (Estimated)
MCK McKesson	$4.76B	$38.47	20.18	15.57	1.25	1.18%	-345.35%	5.85%	8/5/2026 (Estimated)

Latest COR, MCK, CAH, and HUM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2026	Q4 2026	MCK McKesson	$11.56	$11.69	+$0.13	$13.71	$101.35 billion	$96.30 billion
5/6/2026	Q2 2026	COR Cencora	$4.82	$4.75	-$0.07	$8.40	$81.09 billion	$78.36 billion
4/30/2026	Q3 2026	CAH Cardinal Health	$2.79	$3.17	+$0.38	$1.69	$62.10 billion	$60.94 billion
4/29/2026	Q1 2026	HUM Humana	$9.97	$10.31	+$0.34	$9.83	$39.37 billion	$39.65 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CAH Cardinal Health	$2.06	1.00%	+1.02%	31.50%	29 Years
COR Cencora	$2.40	0.87%	+5.79%	18.40%	15 Years
HUM Humana	$3.54	1.01%	+7.20%	37.86%	N/A
MCK McKesson	$3.28	0.42%	+13.68%	8.53%	17 Years

Latest COR, MCK, CAH, and HUM Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/15/2026	HUM Humana	quarterly	$0.8850	1.79%	6/26/2026	6/26/2026	7/31/2026
5/5/2026	CAH Cardinal Health	quarterly	$0.5158	1.05%	7/1/2026	7/1/2026	7/15/2026
4/21/2026	MCK McKesson	quarterly	$0.82	0.45%	6/1/2026	6/1/2026	7/1/2026
5/5/2026	COR Cencora	quarterly	$0.60	0.93%	5/15/2026	5/15/2026	6/1/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CAH Cardinal Health	N/A	0.91	0.48
COR Cencora	3.40	0.95	0.59
HUM Humana	0.66	1.77	1.77
MCK McKesson	N/A	0.85	0.49

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CAH Cardinal Health	87.17%
COR Cencora	97.52%
HUM Humana	92.38%
MCK McKesson	85.07%

Insider Ownership

Company	Insider Ownership
CAH Cardinal Health	0.12%
COR Cencora	0.38%
HUM Humana	0.20%
MCK McKesson	0.08%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CAH Cardinal Health	57,700	234.21 million	233.93 million	Optionable
COR Cencora	51,000	194.56 million	193.82 million	Optionable
HUM Humana	67,060	120.06 million	119.82 million	Optionable
MCK McKesson	43,000	120.20 million	120.11 million	Optionable

COR, MCK, CAH, and HUM Headlines

Recent News About These Companies

McKesson (MCK) Valuation Check After Recent Share Price Rebound And Mixed Fundamental Signals

3 hours ago | finance.yahoo.com

Vestcor Inc Raises Holdings in McKesson Corporation $MCK

June 6 at 7:33 AM | marketbeat.com

Vise Technologies Inc. Purchases 2,912 Shares of McKesson Corporation $MCK

June 6 at 7:07 AM | marketbeat.com

Fjarde AP Fonden Fourth Swedish National Pension Fund Decreases Holdings in McKesson Corporation $MCK

June 6 at 4:26 AM | marketbeat.com

Here is What Analysts Are Saying About McKesson Corporation (MCK)

June 5 at 7:30 PM | insidermonkey.com

Here is What Analysts Are Saying About McKesson Corporation (MCK)

June 5 at 6:25 PM | finance.yahoo.com

McKesson Corporation (NYSE:MCK) Receives Average Rating of "Moderate Buy" from Analysts

June 5 at 3:31 AM | marketbeat.com

3 Cash-Producing Stocks with Promising Prospects

June 4 at 7:27 PM | finance.yahoo.com

Analyst Report: McKesson Corp

June 4 at 3:51 PM | finance.yahoo.com

Top 5 Cheap Stocks With Strong Buy Ratings on Wall Street

June 4 at 2:30 PM | insidermonkey.com

JP Morgan’s Analyst Focus List for June Has 5 Top Passive Income Dividend Picks

June 4 at 9:26 AM | 247wallst.com

McKesson (NYSE:MCK) EVP Thomas Rodgers Sells 123 Shares

June 4 at 8:18 AM | insidertrades.com

TD Asset Management Inc Lowers Stake in McKesson Corporation $MCK

June 4 at 7:24 AM | marketbeat.com

McKesson Corporation $MCK Shares Purchased by Bank of New York Mellon Corp

June 4 at 3:13 AM | marketbeat.com

We Ran A Stock Scan For Earnings Growth And McKesson (NYSE:MCK) Passed With Ease

June 3 at 1:12 PM | finance.yahoo.com

Is McKesson Stock Underperforming the Dow?

June 3 at 7:11 AM | barchart.com

CIBC Asset Management Inc Raises Stock Holdings in McKesson Corporation $MCK

June 3 at 4:30 AM | marketbeat.com

Anchor Capital Advisors LLC Cuts Holdings in McKesson Corporation $MCK

June 3 at 3:13 AM | marketbeat.com

McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions

June 2, 2026 | finance.yahoo.com

Natixis Advisors LLC Trims Holdings in McKesson Corporation $MCK

June 2, 2026 | marketbeat.com

BNP Paribas Has $45.21 Million Position in McKesson Corporation $MCK

June 2, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

COR, MCK, CAH, and HUM Company Descriptions

Cardinal Health NYSE:CAH

$205.79 +4.05 (+2.01%)

Closing price 06/5/2026 03:59 PM Eastern

Extended Trading

$205.75 -0.04 (-0.02%)

As of 06/5/2026 07:57 PM Eastern

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cencora NYSE:COR

$274.94 +4.62 (+1.71%)

Closing price 06/5/2026 03:59 PM Eastern

Extended Trading

$272.55 -2.39 (-0.87%)

As of 06/5/2026 07:59 PM Eastern

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Humana NYSE:HUM

$349.85 +0.05 (+0.02%)

Closing price 06/5/2026 03:59 PM Eastern

Extended Trading

$346.50 -3.35 (-0.96%)

As of 06/5/2026 07:56 PM Eastern

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

McKesson NYSE:MCK

$776.51 +19.56 (+2.58%)

Closing price 06/5/2026 03:59 PM Eastern

Extended Trading

$776.38 -0.14 (-0.02%)

As of 06/5/2026 07:59 PM Eastern

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest COR, MCK, CAH, and HUM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest COR, MCK, CAH, and HUM Earnings

Compare Dividends

Latest COR, MCK, CAH, and HUM Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

COR, MCK, CAH, and HUM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

COR, MCK, CAH, and HUM Company Descriptions

Cardinal Health NYSE:CAH

Cencora NYSE:COR

Humana NYSE:HUM

McKesson NYSE:MCK

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools